Entering text into the input field will update the search result below

Soligenix Enters $10 Million Equity Purchase Agreement

Aug. 03, 2015 9:37 AM ETSoligenix, Inc. (SNGX) StockSNGXBy: Arrow Loop Research, SA News Editor
  • Soligenix (NASDAQ:SNGX) announces it has entered into a $10 million equity purchase agreement with accredited institutional investors, Kingsbrook Opportunities Master Fund LP and River North Equity, LLC. Brean Capital, LLC served as financial advisor for this transaction.
  • Soligenix will file a registration statement with the Securities and Exchange Commission. Once effective, the company will have the right to sell up to $10 million worth of common stock under the terms set forth in the agreement.
  • Proceeds from this transaction will be used to help fund the company's ongoing development initiatives of its late-stage product candidates, including its pivotal Phase 3 clinical study of SGX301 in the treatment of cutaneous T-cell lymphoma.
  • Related tickers: (XON +1.2%)

Recommended For You

More Trending News

About SNGX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNGX--
Soligenix, Inc.